Dr. Eli Peli, OD, MSc
Claim this profileStudies Visual field defect
Studies Homonymous Bilateral Visual Field Defect
1 reported clinical trial
1 drug studied
More about Eli Peli, OD, MSc
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Eli Peli, OD, MSc has experience with
- Field Expansion View
Breakdown of trials Eli Peli, OD, MSc has run
Visual field defect
Homonymous Bilateral Visual Field Defect
Visual Field Loss
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eli Peli, OD, MSc specialize in?
Eli Peli, OD, MSc focuses on Visual field defect and Homonymous Bilateral Visual Field Defect. In particular, much of their work with Visual field defect has involved treating patients, or patients who are undergoing treatment.
Is Eli Peli, OD, MSc currently recruiting for clinical trials?
No, Eli Peli, OD, MSc is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Eli Peli, OD, MSc has studied deeply?
Yes, Eli Peli, OD, MSc has studied treatments such as Field expansion view.
What is the best way to schedule an appointment with Eli Peli, OD, MSc?
Apply for one of the trials that Eli Peli, OD, MSc is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.